Paclitaxel and UFT Plus Oral Calcium Folinate in Pretreated Metastatic Breast Cancer
ByUte Klaassen, MD,David Borquez, MD,Stephanie Lang, MD,Carsten Oberhoff, MD,Andreas Harstrick, MD,Siegfried Seeber, MD, PhD,Steven Benner, MD
Published: | Updated:
This phase I study was designed to determine the maximum tolerated dose (MTD) and dose-limiting side effects of combination treatment with paclitaxel (Taxol) and UFT (uracil and tegafur in a 4:1 molar ratio) plus oral